Insulin Icodec-Abae + AlbuterolModerate
May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae Interactions
21 interactions on record
Insulin Icodec-Abae + AlcoholModerate
May increase or decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae + ClonidineModerate
May increase or decrease blood glucose lowering effect and blunt signs/symptoms of hypoglycemia. Dose adjustment and increased glucose monitoring required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae + ClozapineModerate
May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae + DanazolModerate
May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae + FluoxetineModerate
May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae + GlucagonModerate
May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
May blunt signs and symptoms of hypoglycemia. Increased frequency of glucose monitoring required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae + IsoniazidModerate
May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae + LithiumModerate
May increase or decrease blood glucose lowering effect. Dose adjustment and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae + NiacinModerate
May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae + OctreotideModerate
May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae + OlanzapineModerate
May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
May cause hypoglycemia followed sometimes by hyperglycemia. Dose adjustment and increased glucose monitoring required.
Source: NLP:insulin icodec-abae
May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
May increase risk of hypoglycemia. Dose reductions and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae + ReserpineModerate
May blunt signs and symptoms of hypoglycemia. Increased frequency of glucose monitoring required.
Source: NLP:insulin icodec-abae
Insulin Icodec-Abae + SomatropinModerate
May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae
May decrease blood glucose lowering effect of Awiqli. Dose increases and increased glucose monitoring may be required.
Source: NLP:insulin icodec-abae